Exosens's total assets for Q2 2026 were €895.00M, an increase of 1.83% from the previous quarter. EXOSF total liabilities were €444.20M for the fiscal quarter, a 2.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.